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1  | INTRODUC TION
Angiogenesis is essential for normal embryonic development, and 
plays a key role in pathological conditions related to tumour growth 
and ischaemic cardiovascular diseases. This is a complex process in‐
volving essential signalling pathways such as VEGF, basic fibroblast 
growth factor (bFGF) and Notch in vasculature. Previously published 
results suggested that myeloid progenitor cells play important role 
in angiogenesis.1
We have largely expanded our knowledge about the role of bone 
marrow‐derived cells (BMDC) in stimulating angiogenesis after their 
discovery in 19972 and now their capability to promote vessel formation 
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Abstract
The precise mechanisms of SDF‐1 (CXCL12) in angiogenesis are not fully elucidated. 
Recently, we showed that Notch inhibition induces extensive intussusceptive angio‐
genesis by recruitment of mononuclear cells and it was associated with increased 
levels of SDF‐1 and CXCR4. In the current study, we demonstrated SDF‐1 expression 
in liver sinusoidal vessels of Notch1 knockout mice with regenerative hyperplasia by 
means of intussusception, but we did not detect any SDF‐1 expression in wild‐type 
mice with normal liver vessel structure. In addition, pharmacological inhibition of 
SDF‐1/CXCR4 signalling by AMD3100 perturbs intussusceptive vascular growth and 
abolishes mononuclear cell recruitment in the chicken area vasculosa. In contrast, 
treatment with recombinant SDF‐1 protein increased microvascular density by 34% 
through augmentation of pillar number compared to controls. The number of ex‐
travasating mononuclear cells was four times higher after SDF‐1 application and two 
times less after blocking this pathway. Bone marrow‐derived mononuclear cells 
(BMDC) were recruited to vessels in response to elevated expression of SDF‐1 in 
endothelial cells. They participated in formation and stabilization of pillars. The cur‐
rent study is the first report to implicate SDF‐1/CXCR4 signalling in intussusceptive 
angiogenesis and further highlights the stabilizing role of BMDC in the formation of 
pillars during vascular remodelling.
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is intensively investigated. The domain comes to be multifaceted and 
contradictory data were sometimes arising. The discovery that mono‐
nuclear cells can home to sites of hypoxia and enhance neo‐angiogen‐
esis has faced the possibility of using isolated hematopoietic stem cells 
or endothelial progenitor cells (EPC) for therapeutic vasculogenesis.3 
However, infusion of EPC did not improve neovascularization4,5 sug‐
gesting that a not‐yet‐defined functional characteristic (eg, chemokine 
or integrin receptors mediating homing) is essential for EPC‐mediated 
vascular augmentation after ischaemia.6 During endothelial repair after 
vascular injury and during tumour angiogenesis, BMDC do not seem to 
be involved in re‐endothelialization, stressing their supportive role over 
trans‐differentiation.7,8 For therapeutic application, local enhancement 
of monocyte recruitment might be better suited than systemic infusion 
of monocytic cells, which only leads to a relatively minor increase in 
the number of circulating monocytes. An open question is what drives 
BMDC recruitment to the sites of angiogenesis.
Ischaemia is believed to up‐regulate VEGF or SDF‐1 (CXCL12),9 the 
latter in turn is released to the circulation and induces mobilization of 
progenitor cells from the bone marrow via a MMP‐9—dependent mech‐
anism.10,11 Indeed, SDF‐1 has been proven to stimulate recruitment of 
progenitor cells to the ischaemic tissue.12 SDF‐1 protein levels were in‐
creased during the first days after induction of myocardial infarction.13 
Moreover, overexpression of SDF‐1 augmented stem cell homing and 
incorporation into ischaemic tissues.12,13 Interestingly, hematopoietic 
stem cells were shown to be exquisitely sensitive to SDF‐1 and did not 
react to G‐CSF or other chemokines (eg, IL‐8 and RANTES).14
SDF‐1/CXCR4 axis is crucial in the homing mechanisms of he‐
matopoietic cells and metastasis of solid tumours. In the past few 
years, numerous studies have focused on unravelling the role of this 
signalling in angiogenesis and prove its angiogenic activity in organ 
repair and tumour development. However, the precise mechanisms 
by which SDF‐1 exerts its pro‐angiogenic effects are not fully eluci‐
dated. Since it is supposed to be an angiogenic growth factor, it is a 
good candidate for pro‐ and anti‐angiogenic therapy. It was reported 
that transient disruption of the SDF‐1/CXCR4 axis using CXCR4 
blocking antibody blocked the recruitment of bone marrow‐derived 
cells into the angiogenic sites of tumour tissue, and resulted in an 
inhibition of accelerated tumour growth.15
Recently we have shown that inhibition of Notch signalling in‐
duces extensive intussusceptive angiogenesis by recruitment of 
mononuclear cells.16 Notably, it was associated with increased levels 
of SDF‐1 and CXCR4 chemotaxis factors. Intussusceptive angiogen‐
esis is a process linked to both blood vessel replication and remod‐
elling in development.17,18 It is well documented as a mechanism of 
vascular adaptation in response to different environmental stimuli 
such as chronic systemic hypoxia19 and prolonged inflammation.20 
It is also a mechanism of compensatory vascular growth. For exam‐
ple, capillary repair during kidney recovery in Thy1.1 nephritis pro‐
ceeds through intussusceptive angiogenesis.21 Similarly, the switch 
from sprouting to intussusceptive angiogenesis, found to occur in 
tumours after irradiation therapy, allows the vasculature to main‐
tain its functional properties.22,23 Potential candidates for molecular 
targeting of this angioadaptive mechanism are yet to be elucidated 
in order to improve the currently poor efficacy of contemporary 
anti‐angiogenic therapies. Of major significance is the involvement 
of intussusceptive angiogenesis in pathological conditions such as 
liver nodular hyperplasia,24 in the vasculature of experimental and 
clinical tumours,25,26 in liver metastasis,29 in metastatic tumours of 
the brain30 and in breast cancer progression31 among others.
Despite this variety of roles, attributed to intussusceptive angio‐
genic, most of the current research is focused on sprouting angio‐
genesis because the latter mechanism has been known since many 
decades ago and additionally, there are many experimental models 
related to sprouting angiogenesis. Here, we provide evidence that 
intussusceptive angiogenesis is regulated by SDF‐1/CXCR4 signal‐
ling and suggest some intussusceptive angiogenic roles for CXCR4 
and Tie‐2 positive bone marrow‐derived mononuclear cells (BMDC).
2  | METHODS
2.1 | Animals
Fertilized white leghorn eggs were obtained from commercial breed‐
ers (Fribourg, Switzerland). The eggs were incubated in‐shell for 
3 days at 37°C in humidified (65%) atmosphere, containing 1%‐2% 
CO2. The eggs were opened on day 3 and further incubated at the 
same conditions using shell‐free method32 in petri dishes (Corning 
Incorporated, Corning, NY). The samples were divided into a control 
and experimental groups. There were at least six chicken embryos 
investigated in each group.
MxCre Notch1lox/lox mice on a C57Bl/6 background carrying 
the Cre‐recombinase under the murine Mx1 promoter (described 
in 24). To induce recombination, 300 µg of polyiosinic‐polycytidylic 
acid (pIpC) (InvivoGen, San Diego, CA) was injected intraperitoneally 
in 4‐week‐old mice at days 0, 3 and 6, resulting in efficient deletion 
of Notch1 in the liver already after 1 day. Notch1 deletion was con‐
sistent in liver sinusoidal endothelial cells (LSECs) and hepatocytes 
during the whole observation period.
2.2 | Reagents
Inhibition of Notch signalling was achieved as already described 
(Dimova et  al) by using γ‐secretase inhibitor 1 (GSI‐1) (Calbiochem, 
San Diego, CA, USA). To block SDF‐1/CXCR4 signalling, an an‐
tagonist of CXCR4—a symmetrical bicyclam compound AMD3100 
(Calbiochem), which inhibits SDF‐1 activation of the receptor was 
used, in a dose of 40‐80 mg/kg. AMD3100 application was done 
subsequent to GSI treatment. To stimulate SDF‐1/CXCR4 signalling, 
recombinant SDF‐1 alpha protein (PromoKine, Heidelberg, Germany) 
was used at a dosage of 10 mg/kg, with two times of application dur‐
ing 24 hour‐period of observation in chicken area vasculosa (CAV).
2.3 | Morphometry
Evaluation of vascular parameters was accomplished with Tem 
Imaging Platform software (iTEM). Electronic images were acquired 
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from normally developing CAV in order to obtain baseline data and 
a normal growth curve. From the experimental groups, images were 
taken from treated samples at time point 24 hours. The visualization 
of microvasculature was done by injection of 50 µL of 10%‐fluores‐
cein isothiocyanate‐Dextran 2000 kD (FD‐2000S; Sigma‐Aldrich, 
Munich, Germany) in 0.9% NaCl solution, prior to inspection in 
an epifluorescence microscope (Polyvar‐Reichert, Glattbrugg, 
Switzerland) equipped with a Canon 5D Mark II camera for both 
video recording and acquisition of still images. The still images and 
video sequences of at least four fields of view were obtained per 
application site for further quantitative evaluation. Microvascular 
density and pillar numbers were evaluated using analySIS Software 
5.0 (Soft Imaging System, Muenster, Germany).
2.4 | Transmission electron microscopy
The samples obtained from the area vasculosa and PBS controls har‐
vested at time point 24 hours were immersion‐fixed in 2.5% glutaral‐
dehyde solution buffered with 0.03 mol/L potassium phosphate (pH 
7.4, 370 mOsm). The livers of Notch 1 KO and wild‐type (WT) mice 
were perfused with 2.5% glutaraldehyde in 0.1 mol/L cacodylate 
buffer [pH 7.4, 350 mOsm]). Then the livers were excised, cut into 
small pieces, and immersed in the same fixative.
All samples were then postfixed in 1% OsO4 (buffered with 
0.1 mol/L sodium cacodylate—pH 7.4, 370 mOsm), dehydrated in 
ascending concentrations of ethanol, and embedded in epoxy resin. 
For light microscopy, 1µm‐thick sections were prepared using glass 
knives and stained with toluidine blue. For transmission electron mi‐
croscopy, 80‐90 nm‐thick sections were prepared and mounted on 
copper grids coated with Formvar (polyvinyl formal; Fluka, Buchs, 
Switzerland). They were stained with lead citrate and counterstained 
with uranyl acetate prior to viewing in a Philips EM‐400 electron 
microscope.
2.5 | Vascular casting
Vascular casts were prepared as previously described.33 Briefly, 
CAV vasculature and the vasculature of the murine livers were per‐
fused with a freshly prepared solution of Mercox® (Vilene Company, 
Tokyo, Japan) containing 0.1 mL of accelerator per 5 mL of resin. 
One hour after perfusion, the specimes were transferred to 7.5% 
potassium hydroxide for digestion of tissue, which was effected over 
a course of 2‐3 weeks. After washing, the casts were dehydrated in 
ethanol and dried in a vacuum desiccator. The samples were then 
sputtered with gold to a thickness of 10 nm and examined in a Philips 
XL‐30 SFEG scanning electron microscope.
2.6 | Mononuclear cell counting
Semithin serial sections were obtained and images captured at mag‐
nification 40x using a light microscope (Leica, Leitz DM), equipped 
with Leica DFC480 camera. At least 10 images were taken per sam‐
ple for further quantitative evaluation and at least 10 samples for 
each application were evaluated. The total number of adherent/
extravasated mononuclear cells per vessel circumference was as‐
sessed using analySIS Software 5.0 (Soft Imaging System, Muenster, 
Germany) by means of user‐driven skeletonization of the vascular 
circumference.
2.7 | Bone marrow mononuclear cells isolation
To isolate bone marrow mononuclear cells, 4‐ to 6‐week‐old male 
BALB/c mice (BALB/cByJ; Charles River Laboratories, Freiburg, 
France) were sacrificed and their femurs and tibias collected in 
DMEM (Gibco) supplemented with 10% foetal bovine serum (FBS, 
Sigma‐Aldrich). Bone‐marrow was flushed‐off using PBS with 2% 
FBS and collected in a tube with 2 mmol/L ethylenediaminetet‐
raacetic acid/PBS. The solution was then diluted with 10x volume 
RPMI1640 containing 0.02% collagenase B and 100 U/mL DNase 
and agitated gently at room temperature for 45 minutes. The cells 
were passed through 30 µm nylon mesh, centrifuged and resus‐
pended in PBS. The cell suspension was gently and slowly added 
onto a tube containing the same volume of Histopaque‐1077 (Sigma 
Aldrich, Cat. 10771). After 30 minutes centrifugation, the white 
cellular ring floating over the Ficoll phase (mononuclear cells) was 
collected and transferred into a new tube, filled with 1X PBS and 
centrifuged to wash. At the end cells were re‐suspended in the ap‐
propriate medium.
2.8 | Cell staining
The stock solution of CellTrackerTM Green 5‐Chloromethylfluorescein 
diacetate (10 mmol/L) was diluted to a final working concentration of 
5 µmol/L in serum‐free medium. The working solution was warmed 
to 37°C. The mononuclear BMDC were centrifuged to pellet them 
and aspirate the supernatant. The cells were gently re‐suspended in 
pre‐warmed working solution, then incubated for 15‐45 minutes at 
37°C and centrifuged. The probe solution was replaced with fresh, 
pre‐warmed medium and incubated for another 30 minutes at 37°C.
2.9 | Adhesion assay
To perform adhesion assay, 105 labelled mononuclear BMDC were 
add per well of cultured endothelial cells (on coverslips) for 15 min‐
utes. The wells were washed with PBS, coverslips were fixed with 
3.7% formaldehyde for 15 minutes at room temperature, stained 
with Hoechst dye for 10 minutes, rinsed with water and mounted on 
a slide for counting by microscopy.
2.10 | Mononuclear cells isolation from CAV
Blood was washed out of the vessels of selected CAV samples. This 
was accomplished by injection of PBS. The treated tissue area was re‐
moved; making sure that for each embryo investigated the size of the 
tissue was the same. Tissues from at least 10 embryos for each test 
were then collected for each treatment and for controls. The tissue 
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was cut into small pieces, digested in 500 µL 0.25% trypsin solution 
and 10 µL DNAse for 5 minutes at 37°C. The cell suspension was fil‐
tered through nylon gauze with a defined pore diameter of 30 µm, 
filled with 1X PBS and an equal volume of Histopaque‐1077 was added 
gently. After 30 minutes of centrifugation, the white cellular ring float‐
ing over the Ficoll phase (containing mononuclear cells) was collected, 
filled with 1X PBS and centrifuged for 10 minutes at 400 g to wash.
2.11 | RNA isolation and Real‐time reverse 
transcription‐PCR
Total RNA was extracted from collected mononuclear cells from 
treated and control CAVs, by using High Pure RNA Cells Isolation 
Kit (Roche Diagnostics GmbH, Manheim, Germany). The RNA 
concentrations were determined spectrophotometrically. cDNA 
was synthesized by reverse transcription (1 hour at 37°C) using 
500 ng of total RNA, 2.5 µmol/L of the oligo‐dT primers and 10 U of 
Reverse Transcriptase (Transcription High Fidelity cDNA Synthesis 
Kit, Roche Diagnostics GmbH). The following primer/probe kits 
(Chicken QuantiTest Primer Assay) were purchased from Qiagen: 
Chicken QuantiTest Primer Assay KDR2 (QT01140244), VEGFR1 
(Flt1) (QT00595987), SDF‐1 (CXCL12) (QT01139026), CXCR4 
(QT00590128), Tie‐2 (TEK) (QT00685629), Hes‐1 (QT00589015) 
and FGF2 (QT00599998). Quantitative PCR was performed using 
Real Time PCR (Applied BioSystems 7500 Fast). The fold change in 
expression levels of cDNA were determined from the ∆Ct values 
obtained as compared to ∆Ct values of control samples. In our ex‐
periment we used GAPDH (QT00588973) as housekeeping genes.
F I G U R E  1   Effects of Notch inhibition 
on intussusceptive angiogenesis in the 
chick area vasculosa are mediated by 
SDF‐1/CXCR4 signalling. A, Fluorescein 
isothiocyanate microvasculature 
visualization after different targeted 
treatments. γ‐secretase inhibitor (GSI) 
application or treatment with recombinant 
SDF‐1 protein induced remarkably pillar 
formation (arrows), that is, intussusceptive 
angiogenesis. AMD3100 (CXCR4 
antagonist) simultaneously applied with 
GSI demonstrated repressive effects 
on pillar formation. B, Bar graphs 
representing pillar density (*P < 10‐5, **P 
< 10‐5, ***P < 10‐6) and vessel area density 
(*P < 0.01, **P < 0.01, ***P < 0.01) after 
different applications
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2.12 | Immunofluorescence
Sections from liver samples were obtained at 5 μm, deparaffinized, 
and rehydrated. On dewaxed and rehydrated slides heat induced 
epitope retrieval in citrate buffer pH6 (DakoCytomation) was car‐
ried out for 5 minutes to unmask the epitopes. This was followed 
by blocking with 1% casein for 10 minutes. Incubation with the pri‐
mary mouse antibody SDF‐1 and CXCR4 (Santa Cruz Biotechnology, 
Dallas, USA) overnight at 4°C (dilution 1:150) was followed by ap‐
plication of anti‐mouse IgG‐Cy3 (Sigma c2181) secondary antibody. 
Counterstaining was performed with Hoechst dye.
2.13 | Statistical analysis
Probability associated with a Student's paired t test, with a two‐tailed 
distribution, was considered in a given p value for each comparison.
3  | RESULTS
3.1 | Effect of Notch inhibition on intussusceptive 
angiogenesis is mediated by SDF‐1/CXCR4 signalling
We first analysed the formation of extra‐embryonic vasculature in 
CAV after simultaneous application of GSI (a potent Notch inhibi‐
tor) and AMD3100—an antagonist of CXCR4 receptor. Compared to 
the GSI application alone (Figure 1A), we detected two times less 
number of pillars along the vessels, thus indicating repressive effect 
on intussusceptive microvascular growth (Figure 1A). In contrast, 
treatment with recombinant SDF‐1 protein remarkably promoted 
intussusceptive angiogenesis in the same model, as is visible from 
the augmentation of pillar number by 4.5 times compared to control 
samples (Figure 1B). The microvascular density increased by 34% as 
well.
If vascular‐derived SDF‐1 expression plays an important role 
in inducing intussusception, especially after Notch inhibition, we 
might expect that in Notch1 knockout (KO) mouse the sinusoid ves‐
sels would express high levels of this chemokine before and during 
intussusceptive remodelling. In accordance with this prediction, we 
detected by immunohistochemistry a mosaic distribution of SDF‐1 
protein in sinusoid vessels of Notch1 KO mouse liver already at day 
2 after Notch depletion (Figure 2). By day 8 its expression was al‐
ready extensively spread on all sinusoids with a high intensity and 
remained stable for the next week (Figure 2). In comparison, WT 
mouse liver did not present substantial expression for SDF‐1 during 
this period (Figure 2). These results suggest that vessel‐derived 
SDF‐1 may be responsible for intussusceptive vascular remodelling 
in the liver of Notch1 KO mouse. Similarly, vascular casts revealed 
intensive intussusceptive vessel remodelling (intussusceptive pil‐
lars represented as a small holes in the vascular casts) in the liver 
of Notch1 KO mouse at the corresponding time points (Figure 2; 
Figure S1).
We performed immunofluorescent analysis for CXCR4 expres‐
sion simultaneously with this one for SDF‐1 in Notch1 KO mouse 
and positivity for the receptor was evident in the mononuclear cells 
recruited to the SDF‐1‐positive sinusoidal vessels (Figure S2).
3.2 | Attraction of mononuclear cells to the 
endothelium and their plausible role in vessel 
remodelling
To examine one of the main functional effects of SDF‐1—attraction 
of mononuclear cells, we did in vitro experiment with co‐culture of 
bone marrow monocytes and endothelial cells. We were interested 
to see if the adhesion of BMD cells to the endothelium is compa‐
rable between the Notch inhibition subjects and SDF‐1 treatment 
ones. The effect of adhesion after Notch inhibition and SDF‐1 treat‐
ment was assessed by labelling mononuclear cells with Cell Tracker™ 
green and fluorescent microscopy. We detected comparable number 
of adherent mononuclear cells after GSI and SDF‐1 treatment on en‐
dothelial cells (Figure 3A; Figure S3). The inhibition of endothelial 
cells in culture (HUVEC) by GSI led to more than two times increase 
in SDF‐1 endothelial expression (Figure 3B). Successful GSI blocking 
was assessed by analysing the expression of Hes1 which is the most 
popular Notch target gene. These results suggest that the recruit‐
ment of mononuclear cells to the endothelium in GSI samples is due 
to SDF‐1/CXCR4 signalling. There were considerable shape altera‐
tions in mononuclear cells due to SDF‐1 application (Figure 3C).
Further detailed structural analysis of the vessels was done on 
semithin sections. The number of adherent/extravasated mononu‐
clear cells after SDF‐1 and its blockade by AMD3100 (following GSI 
treatment) in vivo was quantified (Figure 4A). A marked reduction of 
adherent/extravasated cells was observed after blockade of SDF‐1/
CXCR4 signalling in GSI samples (Figure 4A).
A detailed ultrastructural analysis of the vessels after SDF‐1 
treatment in order to investigate the intercellular interactions at a 
higher resolution was performed. Consistent with our hypothesis 
from a previous study for the extravasation of mononuclear cells 
and their participation in pillar formation after Notch inhibition, 
we detected different steps in mononuclear cell behaviour after 
SDF‐1 application: recruitment, attachment and extravasation 
(Figure 4B). Close contacts were observed between mononuclear 
cells in the lumen and endothelial cells from the opposite sites 
(Figure 4B); the extravasated mononuclear cells were integrated 
between the basement membrane and the pedicels of pericytes 
(Figure 4B); the attached/extravasated mononuclear cells make 
retraction/invagination of the basement membrane into the vessel 
lumen (Figure 4B).
3.3 | Angiogenic expression pattern of extravasated 
mononuclear cells
Since the morphological analysis does not give us information about 
the molecular phenotype of the mononuclear cells, we specifically 
isolated these cells after GSI application from the in vivo model 
(CAV) and tried to characterize their expression pattern for some 
specific angiogenic markers, especially surface receptors (Figure 5). 
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F I G U R E  2   A, Significant elevation in 
SDF‐1 sinusoidal expression, assessed 
by immunohistochemistry, (red signal) in 
line with intussusceptive remodelling in 
Notch1 knockout mice. Nuclei stained in 
blue. B, Vascular casts revealed intensive 
vessel remodelling in Notch1 knockout 
mouse liver at the same time point. Pillars 
are indicated by arrows
F I G U R E  3   Adhesion assay. A, Mouse 
bone marrow cells, labeled with the green 
cell tracker 5‐Chloromethylfluorescein 
diacetate (CMFDA), adhere preferably 
to endothelial cells (blue 4′,6-diamidino-
2‐phenylindole dihydrochloride (DAPI) 
staining) after γ‐secretase inhibitor (GSI) 
and SDF‐1 treatment. B, Increase in SDF‐1 
expression after successful GSI blocking, 
assessed by expression of Hes1. C, Shape 
alterations of bone marrow‐derived 
mononuclear cells under SDF‐1 treatment
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Quantitative measurement revealed significantly higher expression 
for CXCR4 membrane receptor in mononuclear cells from treated 
samples compared to controls, as well as to the same extent higher 
expression levels for Tie‐2 receptor, suggesting that these cells are 
CXCR4+ and Tie2+. Expression of bFGF was increased by 2.5 times in 
mononuclear cells after treatment and no changes were detected for 
SDF‐1 expression. The expression levels for VEGFA receptors 1 and 
2 did not show significant differences. These data, together with the 
results for vessel SDF‐1 expression, assumed that the recruitment of 
mononuclear cells during the process of intussusception is exerted 
by the interplay between CXCR4 receptor on the mononuclear cells' 
surface and SDF‐1 ligand expressed by the endothelium. The role of 
these cells is rather physical for pillar formation by supporting the in‐
traluminal invagination of the endothelium. Their positivity for Tie‐2 
opened the question for the involvement of angiopoietin‐2 signalling 
in this process.
3.4 | Positive feedback relation between SDF‐1 
expression and shear stress
As intussusceptive angiogenesis can be initiated only in the presence 
of blood flow, an important aspect is the molecular link between 
shear stress and its effects on the regulation of angiogenesis. As the 
focus of our study here, we wanted to investigate the expression of 
SDF‐1 under an exposure of specifically determined shear stress. 
Human umbilical vein endothelial cells were seeded into 75 cm2 
plates and grown to confluence in DMEM supplemented with 10% 
FBS, 1% antibiotic. After three passages the cells were seeded on 
1 u‐Slide (y‐shaped ibiTreat). After 24 hours the shear stress of 
20 dyne/cm2 was applied for 3 hours, the slides without shear stress 
were kept static for the same time to be used as control. The cells 
afterwards were collected in RNA Latter for RNA extraction. We 
detected high increase (nine times) in the expression levels of SDF‐1 
F I G U R E  4   Area vasculosa adhesion/
extravasation assay. A, Semithin 
section and quantification of adherent/
extravasated cells per vessel area revealed 
mononuclear cells (Mo) attraction and 
recruitment after SDF‐1 application and 
inhibition of the process by AMD3100. 
B, Plausible roles of mononuclear cells in 
vascular recruitment and intussusceptive 
angiogenesis after SDF‐1 treatment. 1, 
circulating Mo; 2, Mo attachment; 3, 
Mo recruitment; 4, Mo extravasation; L, 
lumen; EC, endothelial cells; asterisks, EC‐
pericytes detachment space enabling Mo 
extravasation
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under the applied shear stress (Figure 6A). Inversely, we tested if 
application of SDF‐1 on endothelial cells increases the expression 
of eNOS—a marker of increased shear stress. We found more than 
three times increase in eNOS expression levels (Figure 6B). These 
results suggest a positive feedback loop between shear stress and 
SDF‐1, each of them inducing the other. If this is the case, it could 
be the possible explanation for the rapid expansion of intussuscep‐
tion during the growth and remodelling of the vasculature. Further 
investigations are needed to clarify this observation.
4  | DISCUSSION
Several studies in the recent past allowed distinguishing of sub‐
populations of mononuclear cells existing in the adult bone 
marrow and circulating in peripheral blood that support angio‐
genesis without being incorporated permanently into the newly 
formed vessels, the so‐called circulating angiogenic cells (CAC).34 
Here, we showed that mononuclear cells of bone marrow origin 
are recruited to vessels in response to SDF‐1 endothelial expres‐
sion. Our previous studies demonstrated that extravasating mono‐
nuclear cells stabilize pillars, the hallmarks of intussusception, by 
formation of uropod‐like protrusions and collagen production.16 In 
the current study we have found that they express bFGF, support‐
ing the previous observation. In addition, they were highly positive 
for the expression of CXCR4 and Tie‐2 receptors. Pharmacological 
inhibition of SDF‐1/CXCR4 signalling by small CXCR4 antagonist 
AMD3100 perturbs intussusceptive vascular growth (two times 
less pillar number) and abolishes mononuclear cell recruitment 
in GSI treated samples of CAV. In contrast, treatment of CAV by 
F I G U R E  5   Total fold change in cDNA expression level profiles for receptors CXCR4, Tie‐2, VEGFR1 and VEGFR2, and for growth factors 
SDF‐1 and basic fibroblast growth factor (bFGF) in the exstravasated mononuclear cells (MNC) after PBS and γ‐secretase inhibitor (GSI) 
application in the area vasculosa
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recombinant SDF‐1 protein increased microvascular density by 
34% through augmentation of pillar number by 4.5 times compared 
to control samples. The number of extravasating mononuclear cells 
was four times higher after SDF‐1 application and two times less 
after blocking this signalling pathway. Similarly, Butler et  al showed 
that administration of recombinant SDF‐1 protein within the vitre‐
ous chamber of murine model of proliferative diabetic retinopa‐
thy35 promoted neovascularization and SDF‐1 is both necessary 
and enough for inducing proliferative retinopathy. This finding was 
supported clinically by detection of high vitreal SDF‐1 concentra‐
tion in patients with diabetic retinopathy. The murine model used 
GFP + HSC‐derived progenitor cells and proved their migration 
and incorporation into the sites of ischaemic injury after SDF‐1 
application. The latter authors, however did not highlight the role 
of the cells in the development of functional blood vessels. SDF‐1 
expression was also up‐regulated in a hypoxia‐induced pulmonary 
hypertension mouse model.36 Inhibition of SDF‐1/CXCR4 axis de‐
creases progenitor cells in the lungs, at the same time prevents 
and reverses pulmonary vascular remodelling. GFP+ cells (GFP‐
BMDC?) were visualized in the smooth muscle and adventitial lay‐
ers of the hypoxic pulmonary arteries. In our previous study, after 
Notch inhibition we detected mononuclear cells extravasating 
and participating in the formation of pillars during intussusceptive 
angiogenesis, which is a main mechanism of vascular adaptation. 
Here we confirm that extravasation and recruitment of BMDC is 
due to increased expression of SDF‐1, and occurs concomitantly 
with intussusceptive angiogenesis both in the CAV and in the 
mouse model. Ultrastructural investigation under TEM combined 
with molecular analyses suggest, that the BMDC are CXCR4‐posi‐
tive and are as such attracted to the SDF‐1‐positive endothelium 
and physically support intraluminal endothelial invagination. In 
the CAV model with simple tumour‐like vessels we observed how 
the BMDC are integrated between endothelial cells and the peri‐
cytes. Further looking at their morphology, we noticed formation 
of uropod‐like structures during their adherence to the endothe‐
lium. The in vitro experiments indicated the same extent of BMDC 
adhesion after GSI and SDF‐1 treatment and formation of uropods 
after SDF‐1 application, assuming the adhesion and uropod forma‐
tion were mainly due to SDF‐1. Renewed interest in cell shape has 
been prompted by a recent abundance of evidence indicating that 
cell polarity is essential for the biology of motile cells. Uropod is 
defined as a protrusion of motile cells, important for intercellular 
adhesion, cell migration, apoptosis and vesicle trafficking. Recently 
the mechanism of uropod formation was described, as the trigger‐
ing event is cell polarization by chemotaxis molecules.37 SDF‐1 
regulates adhesion, motility and cell shape in tumour progres‐
sion.38 They described morphological changes from round to po‐
lygonal shape, including the formation of neurite‐like projections, 
increased membrane ruffling, and more frequent filopodia and 
uropod formation in response to SDF‐1. We suggest that SDF‐1 
influences protrusion formation in mononuclear cells, facilitating 
their participation in pillar development during intussusceptive an‐
giogenesis. This is the first study reporting connection between 
SDF‐1 endothelial expression and intussusceptive mode of angio‐
genesis. A comprehensive study for SDF‐1 expression in vessels 
was done by Salvucci et  al.39 They detected the presence of SDF‐1 
in endothelial cells of capillaries in bone marrow and skin, as well 
as in the endothelium lining umbilical veins, the chorionic villi, and 
the high endothelial venules in lymph nodes. Although SDF‐1 is not 
expressed in the endothelia of capillaries from many organs in nor‐
mal conditions (such as kidneys, brain, skeletal muscles, lung and 
liver), it is encountered in the capillaries from the same organs in 
pathological conditions, such as glioblastoma multiforme, infarcted 
brain tissue, Burkitt lymphoma tissue and lobular capillary heman‐
gioma. This suggests that SDF‐1 expression could be induced in 
endothelial cells during new vessel formation. We demonstrated 
SDF‐1 positivity in the endothelium of liver sinusoidal vessels of 
Notch1 KO mice, representing regenerative hyperplasia by means 
of intussusception, but SDF‐1 was not detected in WT mice with 
normal liver structure. The intraluminal endothelial protrusions 
were also positive for SDF‐1 in the case of capillary hemangioma, 
described in the above‐mentioned study.39
SDF‐1, when expressed in the bone marrow and various tis‐
sues, is able to regulate trafficking, localization and function of im‐
mature and mature leukocytes, including monocytes, neutrophils, 
dendritic cells and T lymphocytes.40 All these immune cells play 
important roles in tumour angiogenesis and vascularization. It is 
well known that blocking of SDF‐1/CXCR4 axis results in preven‐
tion or delay of tumour recurrence after irradiation by inhibiting 
the recruitment of CD11b+ monocytes/macrophages that partic‐
ipate in tumour revascularization.41 SDF‐1/CXCR4 signalling has 
pivotal role in mast cell (MC) recruitment in tumour tissue42 and 
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MC produce pro‐angiogenic chemokines in response to SDF‐1,43 
thus exerting important angiogenic activity. Mononuclear cells 
adherence to endothelium was four times more after treatment 
with recombinant SDF‐1 protein. For therapeutic purposes, im‐
provement of monocyte recruitment to the injured site might 
be more suitable than injection of monocytic cells in circulation, 
which results in only slight increase in the number of circulating 
monocytes. We demonstrated that blocking SDF‐1/CXCR4 signal‐
ling clearly abrogated the recruitment of mononuclear cells to the 
vessels, at the same time reducing pillar formation respectively 
intussusceptive angiogenesis.
Despite the important role of intussusception in vessel for‐
mation and remodelling, most of the existing studies are focused 
on the better known mechanism of sprouting angiogenesis. Thus, 
the mechanism of intussusceptive angiogenesis has not been ade‐
quately covered contemporary by investigators in the field of angio‐
genesis research. Intussusception is an alternative to the sprouting 
mode of angiogenesis.44 The advantage of this mechanism of vas‐
cular growth is that blood vessels are generated more rapidly and 
the capillaries thereby formed are less leaky.45 Regarding molec‐
ular regulation, very little is known of the molecular factors with 
potential significance in intussusceptive angiogenesis. Application 
of the essential angiogenic factors VEGF and bFGF in the arterio‐
venous loop model demonstrated advanced neovascularisation in 
the phase of remodelling by a higher incidence of intussusception, 
compared to controls.46 It was found that neovascularization in‐
duced by VEGF plus bFGF is mediated by SDF‐1/CXCR4 signalling 
and that SDF‐1 neutralization reduced growth factor‐triggered 
neovascularization by approximately 84%‐86%.39 In addition, our 
experiments on HUVEC demonstrated positive feedback between 
shear stress and SDF‐1. Recently, it was proposed that Notch1 is 
atheroprotective and acts as a mechanosensor in adult arteries, 
where it integrates responses to laminar shear stress,47 as well as 
that chemokine receptor CXCR4 pathway is the key regulator of 
Notch‐dependent vessel growth.48
In conclusion, our study is the first to implicate SDF‐1/CXCR4 sig‐
nalling in the mechanism of intussusceptive angiogenesis. Plausibly, 
BMDC play an important physical and stabilizing role in the forma‐
tion of pillars during vascular augmentation.
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